interferon treatment is problematic for
recurrentRecurrent cystitis HCV after liver transplantation. it is more difficult to tolerate in part due to the other meds one needs to take. SVR are still dependent on genotype and unfortunately are lower than usual with genotype 1 SVR about 20-25% in most studies. this occurs in part due to the need to dose reduce or suboptimally dose patients due to the side affects, such as anemia. everyone is viral load (+) after a liver transplant and when the liver tests rise a liver biopsy is indicated which might then show
recurrentRecurrent cystitis HCV.
i hope this helpful
Mike
I am SVR and a transplant recipient. I was transplanted in June 2000 and stopped treatment in June 2004. I test monthly with Heptimax (sensitivity of < 5 IU/ml) and have been consistently undetectable since April 2003. I treated for 73 weeks.
My question is:
Do you believe that a liver transplant recipient SVR (or a non-transplant SVR, for that matter) might still show active HCV on biopsy?
And, if you do believe that it is possible, how common is it and how significant is it?
I was biopsied in June of 2006 and HCV was seen, albeit at a very low viral load.
Thank you, Mike
Mike